May 05, 2021 7:30 am EDT Heat Biologics Provides First Quarter 2021 Business Update; Reports Continued Progress on Oncology and COVID-19 Vaccine Programs
Apr 12, 2021 7:30 am EDT Heat Biologics Announces New Preclinical Data on PTX-35, Demonstrating Decreased Regulatory T-cell (Treg) Activity and Delayed Tumor Progression at American Association for Cancer Research (AACR) Annual Meeting 2021
Mar 08, 2021 7:30 am EST Heat Biologics to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
Feb 09, 2021 7:30 am EST Heat Biologics Announces Positive Interim Survival Data from Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial
Jan 27, 2021 7:30 am EST Heat Biologics Announces Publication of Additional Preclinical COVID-19 Vaccine Results
Jan 20, 2021 7:30 am EST Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021